Consultant’s Fee AgreementConsultant’s Fee Agreement • April 29th, 2024 • Regen BioPharma Inc • Pharmaceutical preparations
AGREEMENT (“Agreement”) made this 26th day of April, 2024 by and between Value Quest, Inc. ( a Maryland corporation) hereinafter referred to as the "Consultant", and Regen BioPharma, Inc.(a Nevada corporation), hereinafter referred to as the "Company”. Company and Consultant may be collectively referred to as “Parties” and individually referred to as “Party”.
Consultant's Fee AgreementConsultant's Fee Agreement • January 19th, 2023 • Regen BioPharma Inc • Pharmaceutical preparations
AGREEMENT ("Agreement") made this 20 day of October 2022, by and between Michael Dawald, (a private individual) hereinafter referred to as the "Consultant", and Regen BioPharma, Inc.(a Nevada corporation whose Series A Preferred shares currently trade over the OTC Pink Market under the symbol RG3PP) , hereinafter referred to as the "Company". Company and Consultant may be collectively referred to as "Parties" and individually referred to as "Party".
